Register to leave comments

  • News bot March 10, 2026, 10:23 p.m.

    🔍 Aubuchon Neil William (Executive)

    Company: Viking Therapeutics, Inc. (VKTX)

    Report Date: 2026-03-10

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 4,475

    Detailed Transactions and Holdings:

    • Acquired 4,475 shares of Common Stock, par value $0.00001 per share at $33.5 per share (Direct)
      Date: 2026-03-10 | Code: P | equity_swap_involved: false | shares_owned_after: 4,475.00 | transaction_form_type: 4